ClinicalTrials.gg
CompletedNCT06870721Updated Mar 11, 2025

Long Head of Biceps as an Anterior Dynamic Sling for Recurrent Anterior Shoulder Dislocation

An interventional study of arthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation in Shoulder Dislocation, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 32 Years. Per ClinicalTrials.gov, last updated 2025-03-11.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Mar 2022, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
20 Years to 32 Years
Sex
All
01

Study summary

Purpose: To evaluate the functional outcomes of arthroscopic onlay dynamic anterior stabilization (DAS) using the long head of biceps (LHB) tendon for treatment of anterior glenohumeral instability (AGI) with limited to subcritical glenoid bone loss (GBL).

Read the detailed description

Twenty-five patients underwent arthroscopic DAS using LHB between March 2022 and October 2022 for treatment of anterior glenohumeral instability (AGI) with limited to subcritical glenoid bone loss (GBL) were included in a prospective study with a minimum follow-up period of 2 years. The shoulder functional outcomes were assessed using the Rowe and the Quick Disabilities of Arm, Shoulder and Hand (Quick DASH) scores both preoperative and at 2 years follow-up. Magnetic resonance imaging (MRI) at 6 months after surgery to evaluate LHB tendon healing to the anterior glenoid.

02

Conditions studied

  • Shoulder Dislocation

Browse trials for

Keywords

  • Dynamic anterior stabilization; onlay; glenohumeral instability.
03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

This study's enrollment of 25 is below the median of 60 across 71 interventional studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 32 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

The inclusion criteria were

  • Patients complaining of AGI, with one or more events of anterior shoulder dislocation.
  • Associated limited (\<13.5%) to subcritical (\<25%) GBL.
  • Positive anterior shoulder apprehension.

The exclusion criteria were

  • Associated critical GBL (≥25%).
  • Concomitant LHB lesion or rupture.
  • Multidirectional or voluntary shoulder instability.
  • Prior arthroscopic shoulder stabilization procedure.
  • Concomitant rotator cuff tears.
  • Acute proximal humerus fractures of the involved shoulder.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    arthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation

    arthroscopic dynamic anterior stabilization using Long head of biceps as for recurrent anterior shoulder dislocation arthroscopic transfer of the Long head of biceps to the anterior glenoid inpatients with recurrent shoulder dislocation

    Procedure: arthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation

Interventions

  • Procedurearthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation

    arthroscopic dynamic anterior stabilization transferring long head of biceps to the anterior glenoid in patients with recurrent anterior shoulder dislocation

06

What researchers measure

Primary outcomes

  1. rowe score

    shoulder score, the maximum is 100, the minimum is zero, the higher score means a better outcome

    Time frame: baseline, and 2 years postoperative

  2. Quick Disabilities of Arm, Shoulder and Hand

    shoulder score, the maximum is 100, the minimum is zero, the higher score means a worse outcome

    Time frame: baseline, and 2 years postoperative

07

Study locations

1 site
  • Faculty of Medicine, Cairo University
    Giza, Cairo, Egypt
08

References and documents

Publications

  • Wu C, Xu J, Fang Z, Chen J, Ye Z, Wang L, Kang Y, Zhao S, Xu C, Zhao J. Arthroscopic Dynamic Anterior Stabilization Using Either Long Head of the Biceps or Conjoined Tendon Transfer for Anterior Shoulder Instability Results in a Similarly Low Recurrence Rate. Arthroscopy. 2023 Jul;39(7):1618-1627. doi: 10.1016/j.arthro.2022.12.040. Epub 2023 Jan 25. PubMed 36708745 ↗
  • Collin P, Nabergoj M, Denard PJ, Wang S, Bothorel H, Ladermann A. Arthroscopic Biceps Transfer to the Glenoid With Bankart Repair Grants Satisfactory 2-Year Results for Recurrent Anteroinferior Glenohumeral Instability in Subcritical Bone Loss. Arthroscopy. 2022 Jun;38(6):1766-1771. doi: 10.1016/j.arthro.2021.11.043. Epub 2021 Dec 7. PubMed 34883198 ↗
  • de Campos Azevedo C, Angelo AC. Onlay Dynamic Anterior Stabilization With Biceps Transfer for the Treatment of Anterior Glenohumeral Instability Produces Good Clinical Outcomes and Successful Healing at a Minimum 1 Year of Follow-Up. Arthrosc Sports Med Rehabil. 2023 Feb 23;5(2):e445-e457. doi: 10.1016/j.asmr.2023.01.012. eCollection 2023 Apr. PubMed 37101880 ↗
  • Milenin O, Toussaint B. Labral Repair Augmentation by Labroplasty and Simultaneous Trans-Subscapular Transposition of the Long Head of the Biceps. Arthrosc Tech. 2019 Apr 26;8(5):e507-e512. doi: 10.1016/j.eats.2019.01.010. eCollection 2019 May. PubMed 31194141 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06870721
Lead sponsor
Cairo University
Responsible party
Mohamed hussein khalil (principal investigator, Cairo University) — Principal investigator
First posted
Mar 11, 2025
Start date
Mar 1, 2022
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Mar 11, 2025

Study contacts

mohamed H khalil, M.D
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion